Wealthcare Advisory Partners’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,205
| Closed | -$37K | – | 1362 |
|
|
2021
Q1 | $37K | Buy |
+1,205
| New | +$37K | ﹤0.01% | 985 |
|
|
2020
Q2 | – | Sell |
-205
| Closed | -$3K | – | 984 |
|
|
2020
Q1 | $3K | Hold |
205
| – | – | ﹤0.01% | 1242 |
|
|
2019
Q4 | $6K | Hold |
205
| – | – | ﹤0.01% | 1070 |
|
|
2019
Q3 | $6K | Hold |
205
| – | – | ﹤0.01% | 1036 |
|
|
2019
Q2 | $6K | Hold |
205
| – | – | ﹤0.01% | 1023 |
|
|
2019
Q1 | $7K | Hold |
205
| – | – | ﹤0.01% | 892 |
|
|
2018
Q4 | $6K | Hold |
205
| – | – | ﹤0.01% | 896 |
|
|
2018
Q3 | $9K | Hold |
205
| – | – | ﹤0.01% | 873 |
|
|
2018
Q2 | $8K | Buy |
205
+100
| +95% | +$3.9K | ﹤0.01% | 897 |
|
|
2018
Q1 | $3K | Hold |
105
| – | – | ﹤0.01% | 925 |
|
|
2017
Q4 | $4K | Hold |
105
| – | – | ﹤0.01% | 832 |
|
|
2017
Q3 | $4K | Buy |
+105
| New | +$4K | ﹤0.01% | 686 |
|